Solriamfetol Real World Experience Study (SURWEY): Initiation and Titration Strategies Among Physicians Prescribing Solriamfetol for Patients with Narcolepsy from Germany von Winter, Y., Kallweit, U., Kotterba, S., Benes, H., Burghaus, L., Koch, A., Girfoglio, D., Setanoians, M., Mayer, G.

Volltext

Solriamfetol Real World Experience Study (SURWEY): Safety, Effectiveness, and Experience During Follow-Up for Patients with Narcolepsy from Germany von Kallweit, U., Winter, Y., Kotterba, S., Benes, H., Burghaus, L., Koch, A., Girfoglio, D., Setanoians, M., Mayer, G.

Volltext

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion von BISSETT, D, SETANOIANS, A, CASSIDY, J, GRAHAM, M. A, CHADWICK, G. A, WILSON, P, AUZANNET, V, LE BAIL, N, KAYE, S. B, KERR, D. J

Volltext

Multicentre phase II pharmacological evaluation of rhizoxin von McLeod, HL, Murray, LS, Wanders, J, Setanoians, A, Graham, MA, Pavlidis, N, Heinrich, B, ten Bokkel Huinink, WW, Wagener, DJTh, Aamdal, S, Verweij, J

Volltext

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9 von McLeod, H.L., Graham, M.A., Aamdal, S., Setanoians, A., Groot, Y., Lund, B.

Volltext

Phase I and pharmacokinetic study of flavone acetic acid von KERR, D. J, KAYE, S. B, CLAVEL, M, CASSIDY, J, BRADLEY, C, RANKIN, E. M, ADAMS, L, SETANOIANS, A, YOUNG, T, FORREST, G, SOUKOP, M

Volltext

Phase I and pharmacokinetic study of rhizoxin von BISSETT, D, GRAHAM, M. A, KERR, D. J, SETANOIANS, A, CHADWICK, G. A, WILSON, P, KOEIR, I, HENRAR, R, SCHWARTSMANN, G, CASSIDY, J, KAYE, S. B

Volltext

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups von McLeod, H L, Murray, L S, Wanders, J, Setanoians, A, Graham, M A, Pavlidis, N, Heinrich, B, ten Bokkel Huinink, W W, Wagener, D J, Aamdal, S, Verweij, J

Volltext

Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9. EORTC Early Clinical Trials Group von McLeod, H L, Graham, M A, Aamdal, S, Setanoians, A, Groot, Y, Lund, B

Volltext

Prelinical and Phase I Studies With Rhizoxin to Apply a Pharmacokinetically Guided Dose-Escalation Scheme von Graham, M. A., Bissett, D., Setanoians, A., Hamilton, T., Kerr, D. J., Henrar, R., Kaye, S. B.

Volltext

Phase I clinical study of LL-D49194α1 with retrospective pharmacokinetic investigations in mice and humans von CASSIDY, J, GRAHAM, M. A, TEN BOKKEL HUININK, W, MCDANIEL, C, SETANOIANS, A, RANKIN, E. M, KERR, D. J, KAYE, S. B

Volltext

Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme von GRAHAM, M. A, BISSETT, D, SETANOIANS, A, HAMILTON, T, KERR, D. J, HENRAR, R, KAYE, S. B

Volltext

Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester) von KERR, D. J, KAYE, S. B, SOUKOP, M, GRAHAM, J, CASSIDY, J, HARDING, M, SETANOIANS, A, MCGRATH, J. C, VEZIN, W. R, CUNNINGHAM, D, FORREST, G

Volltext

Flavone acetic acid: a nonlinear pharmacokinetic model von GOUETTE, A, KERR, D. J, KAYE, S. B, SETANOIANS, A, CASSIDY, J, BRADLEY, C, FORREST, G, SOUKOP, M

Volltext

Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTG von Cassidy, J, Graham, M A, Ten Bokkel Huinink, W, McDaniel, C, Setanoians, A, Rankin, E M, Kerr, D J, Kaye, S B

Volltext

Phase I clinical and pharmacokinetic study of LY 195448 von CASSIDY, J, LEWIS, C, ADAMS, L, SETANOIANS, A, BAYSSAS, M, BODER, G. G, RANKIN, E. M, KAYE, S. B

Volltext

Phase I clinical study of LL-D49194?1 with retrospective pharmacokinetic investigations in mice and humans von Cassidy, James, Graham, Martin A., Huinink, Wim Ten Bokkel, McDaniel, Cathy, Setanoians, Albert, Rankin, Elaine M., Kerr, David J., Kaye, Stanley B.

Volltext

Formulation of 1,3,5-triglycidyl-S-triazinetrione (α-TGT) for intravenous injection von Azmin, M.N., Setanoians, A., Blackie, R.G.G., Whitehill, D., Stuart, J.F.B.

Volltext

A clinical and pharmacokinetic phase I study of 1,2,4-triglycidylurazol (TGU, NSC 332488) von Cunningham, D., Soukop, M., Stuart, J.F.B, Setanoians, A., Gilchrist, N.L., Forrest, G.J., Kaye, S.B.

Volltext